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Preface
The ﬁeld of „heavy ion tumor therapy“ covers a broad 
scientiﬁc and technical spectrum. It is a challenge to 
write a booklet on this topic for physicians, students, 
patients as well as other interested scientists.
To help make the content more transparent, we divided 
it in several chapters and indicated the importance of 
the text by using different fonts.
The reader should get a ﬁrst impression by looking 
at the ﬁgures and reading the titles. The main text 
provides for a more detailed description of the subject 
matter. Finally, some special topics are explained which 
are frequently asked after lectures. Without getting 
involved in heavy ion therapy as such, these sections 
focus on readers who show a special interest in particle 
therapy. 
This booklet is not a scientiﬁc publication. For this 
reason, it does not include a detailed list of publications. 
A more complete list of references is provided at the end 
of the review papers. These reviews are recommended 
for physicians and students with a greater than normal 
interest.
Finally the booklet includes photographs of the therapy 
and the biology labs at GSI to illustrate the text. In 
addition, the booklet shows 15 drawings by Soﬁa 
Graff. These drawings were made during therapy 
sessions and vividly display the impressions made 
during these sessions.
The therapy sections of this booklet describe the 
principles and technical realization of heavy ion 
therapy at GSI, the so called "pilot project". It was 
realized in the years from 1993 – 1997 in collaboration 
with the FZR-Dresden, the Radiological Clinic and 
the German cancer research center in Heidelberg.
I would like to thank all the people who were 
involved in the construction of the project and who 
are now running the facility. To our great satisfaction 
the pilot project and its results had a positive effect 
on the ﬁeld of external tumor therapy. Meanwhile
a Heidelberg Ion Therapy HIT is under construction 
and a second project was started at the University 
of Marburg. Other projects in Germany and Europe 
are coming up as well. HIT will start its' operation at 
the beginning of 2008. Then the pilot project at GSI 
will be terminated after 10 years of very successful 
operation, successful for many patients but also 
successful in developing and implementing new 
ideas to the ﬁeld of ion beam therapy.
           Gerhard Kraft
                May 2007
Heavy ion therapy is a novel technique of high precision 
external radiotherapy. It yields a better perspective for tumor 
cure of radio-resistant tumors. Heavy ion therapy is not 
a general solution for all types of tumors. As compared to 
conventional radiotherapy, heavy ion radiotherapy has the 
following advantages:
Higher tumor dose and improved sparing 
of normal tissue in the entrance channel 
More precise concentration of the dose in the target
volume with steeper gradients to the normal tissue 
Higher radiobiological effectiveness for tumors
which are radio-resistant during conventional
therapy
•
•
•
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These properties make it possible to treat radio-resistant 
tumors with great success - including those in close vicinity 
to critical organs. 
On December 13, 1997, the first patient was treated with heavy ions at GSI, 
the German Heavy Ion Research Center. This was the first tumor therapy with 
carbon ions in Europe and the first Intensity Modulated Particle Ion Therapy 
IMPT worldwide. The heavy ion irradiation was the result of four years of 
constructing the therapy unit at GSI and 20 years of research in radiobiology 
and physics. In addition, a prototype of the intensity modulated beam scanning 
had been constructed and tested at GSI 's heavy ion accelerator SIS from 1988 
to 1991. 
Radiobiological research showed that carbon ions represent the ideal beam for 
the treatment of deep-seated and radio-resistant tumors: first, the low dose in 
the entrance channel causes mostly repairable damage. Second, the high dose 
at the end of the beam combined with the high radiobiological effectiveness 
guarantees a very effective inactivation of radio-resistant tumors. Minimal 
lateral scattering results in millimeter precision at the target. In addition, the 
use of carbon beams made it possible to localize the beam inside the patient 
for the first time: carbon beams produce a small amount of instable isotopes 
during their passage through the tissue of the patient. Some of these isotopes 
such as 10C and 11C are positron emitters. Using a camera for positron emis-
sion tomography PET, 
the decay of these iso-
topes can be measured 
from the outside of the 
patient. This allows 
reconstructing their 
position and hence 
the monitoring of 
particle delivery. As 
a result, the beam in 
radiotherapy can be 
controlled for the first 
time inside the pati-
ent during the course 
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Fig.1: Preparing a patient for heavy ion precision therapy.
of therapy. From the beginning PET imaging of the 
beam inside the patient was a very important quality 
assurance. It allowed applying the novel scanning 
system to patients after a very short test phase. Up to 
now more than 340 patients have been irradiated at 
GSI with great success. First, patients with tumors in 
the head and neck area were irradiated. Although, 
the geometry of this target volume is very complex at 
these sites, masks can be used for precise alignment 
of the head with respect to the beam to allow precise 
irradiation of complex target volumes. Later on treat-
ment was extended to tumors along the spinal cord. 
Patients with prostate tumors are treated since 2006. 
For spinal cord and prostate irradiations, a body cast 
is used for patient positioning.
At present, it is not possible to treat tumors with the 
scanning system in the thorax or abdomen because 
organs and target volumes move according to the 
patient's breathing and heart beat. In combination 
with a scanned beam, movement of the target volu-
me destroys the homogeneity and precision of the 
irradiation. However, the scanning process is quick 
enough to follow the breathing motion and hence to 
compensate for tumor movement. First experiments 
showed feasibility, but it will take additional time to 
transfer this technique to clinical routine. At present, 
irradiation of moving organs is one of the main points 
of the biomedical research and development in the 
GSI biophysics department. Another radiobiological 
research area is the extension of carbon ion therapy 
to other, more frequent tumors, such as gliomas or 
lung carcinomas.
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Fig.2: Treatment plan for carbon 
therapy of a large target volume 
in the base of the skull. The linear 
dose-scale ranges from red 100% 
of the prescribed dose to magenta 
(10%).
In parallel to the research mentioned above and the pilot project in progress, 
GSI is responsible for the technical construction of a heavy ion therapy unit 
at Heidelberg HIT. For a similar project in Pavia, Italy GSI has delivered 
the injector. Recently, GSI has transferred exclusive patent licenses for all 
therapy know-how to Siemens Medical Solutions. In addition, a contract for 
the transfer of know-how between these partners has been signed. Based 
on this transfer of know-how and the longstanding expertise of Siemens, 
Siemens Medical Solutions is now able to offer the leading heavy ion therapy 
system all over the world. A first unit will be constructed by Siemens Par-
ticle Therapy at Marburg, Germany. Other German universities as well as 
other European and Asian countries plus the US have shown strong interest 
in particle therapy. For many projects, the necessary investment of more 
than 100 Mio € presented a hurdle with respect to timely realization. 
In the following pages, the physical and radiobiological basis, the technical 
realization and possible future developments are described. These pages 
are considered to be the basic information for physicians, patients, and 
students. Literature for the specialist is listed at the end of this brochure. 
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Physical basis of heavy ion therapy
The maximum advantage of ion beams compared 
to conventional photon irradiation (x-rays, gamma 
rays, high energy photons) is the different depth-
dose distribution (Fig. 3). For photons the dose 
decreases exponentially after an initial maximum 
located a few centimeters under the skin. In con-
sequence, for irradiations of a deep seated tumor 
with a single entrance channel, the dose before the 
tumor is larger than the dose in the target volume. 
In order to reach a high dose in the tumor with 
tolarable damage in normal tissue, many entran-
ce channels are used to irradiate the tumor in a 
"crossfire" technique. Using this technique, the un-
wanted integral dose is not reduced but rather dis-
tributed over a larger volume. In modern Intensity 
Modulated Radiotherapy IMRT, up to 10 entrance 
channels are used. Using special multileaf collima-
tors, the intensity and the contours of each channel 
are modulated in such a way that the target volu-
me is finally exposed conformal with a homogenous 
dose (Fig. 4).
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Fig. 3: Depth-dose distribution of photon and 
particle beams. In the case of photons, the dose 
decreases exponentially after a maximum in 
the beginning. In contrast, particle beams have 
a dose maximum at the end of the range. This 
maximum can be shifted across the tumor. 
Fig. 4: Comparison of carbon irradiation (left) and photon irradiation 
(right). For photon IMRT, nine channels are used which distribute the 
dose to the normal tissue. For carbon therapy with a scanned beam, the 
dose in the only two entrance channels is much smaller than for IMRT. 
In general, IMRT produces excellent dose distribu-
tion over the target volume, however, at the cost of 
a high integral dose in normal tissue. 
Ions have different physical interactions than 
photons and a more favorable depth-dose 
distribution in the tissue. Only by using heavy 
ion beams is it possible to dramatically reduce 
the dose to normal tissue. 
At present, light hydrogen ions (protons) or the 
heavier carbon ions are used in therapy. They are 
produced in ion sources and accelerated up to 50% 
of the speed of light in order to reach the neces-
sary depth in the patient. A typical therapy beam 
consists of 1 million to 10 million carbon ions per 
second or 100 times more proton ions.
Ions
Ions are positive charged atoms. These 
are atoms where one or many negative 
electrons are removed. In daily life, we 
ﬁnd ions, for instance, in neon light tubes. 
There a few electrons are accelerated by 
an electrical ﬁeld. In collisions these few 
electrons produce other electron-ion 
pairs. During this process UV radiation is 
emitted, which produces some visible light 
during interactions with the phosphorus 
that has been deposited at the glass tube. 
For tumor therapy, ions are produced in a 
similar way in an ion source and injected 
in the accelerator.
Because of their charge, the ions interact mainly 
with the electrons of the penetrated tissue. At the 
high initial speed, this interaction is short and 
only little energy is transferred to the tissue. With 
increasing depth, the ions are slowed down and 
the local interaction becomes longer, transferring 
a higher dose to the tissue. Therefore, the dose 
increases at the end of the ion range to very high 
values, the so called Bragg maximum. After the 
Bragg peak, the dose decreases to zero when the 
ions come to rest. All together this yields a depth-
dose distribution optimal for therapy: a low dose 
in the entrance channel in normal tissue and a 
large dose at the end of penetration in the tumor 
volume.
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In 1946, the great advantages of heavy particle 
depth-dose distributions compared to conventio-
nal irradiation have been recognized by R. Wilson, 
when he measured the depth-dose profiles of pro-
tons and carbon ion beams at the Berkeley cyc-
lotron. But it took almost 10 years from his first 
publication until particles were applied to the first 
patient. In these years, LBL Berkeley and in par-
allel Harvard Cyclotron/MGH at Boston developed 
a simple, but very efficient procedure for patient 
treatment that allowed adaptation of the very 
sharp Bragg maximum to the target volume. 
Intensity Modulated Particle Therapy using the rasterscan technique
Ions are charged particles and can be deflected with magnetic fields. Therefore, it is possible to replace 
the initially used passive modulation systems with active systems where the beam is laterally deflected 
by magnets and modulated in depth by an energy variation in the accelerator. In clinical application, the 
target volume is dissected into layers of equal ion energy produced by different energies of the heavy ion 
In a first step scattering foils enlarge the beams 
laterally to the extension of the target. Then vari-
able ridge filters and patient-specific compensa-
tors are used to modulate the range of the beam 
so that Bragg maxima cover the target’s extension 
in depth. With this technique, a higher dose to the 
target volume could be applied at similar or smal-
ler doses to the normal tissue than in conventional 
photon therapy. This was a very efficient step for 
tumor therapy of deep-seated tumors at this time 
and is still used at most centers today. 
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Fig. 5: The tumor is dissected in slices. Each isoenergy slice is cove-
red by a grid of pixels for which the number of particles has been 
calculated before hand. During irradiation, the beam is guided by the 
magnetic system in a row-by-row pattern from pixel to pixel (Fig. 7).
synchrotron. For irradiation, each layer is covered by a grid 
of pixels and the beam is scanned in a row-by-row pattern 
over these pixels.
During irradiation of the deeper, more distal layers with 
the Bragg maximum, the proximal layers are partly pre-ir-
radiated. This has to be corrected for and yields in general 
an inhomogeneous particle distribution for all individual 
layers.
In addition, the variation of the relative biological effective-
ness RBE has to be taken into account in heavy ion treat-
ment planning. This results in an even larger variation of 
particle coverage in each slice, however, it is necessary for 
a homogenous distribution of the biological effect over the 
complete tumor volume.
The novel technique of beam scanning is in principal the 
same technique as producing a picture using an electron 
beam in a TV set. The picture is divided into lines and 
separate picture points (pixels) and the beam is guided 
intensity modulated from pixel to pixel (Fig. 6).
In addition, the tumor treatment system is able to produce 
a 3-dimensional "image". Using the beam energy variation, 
the "pictures" can be stacked in depths. Therefore a 3-di-
mensional target volume can be exactly painted with the 
beam. Even critical organs that are enclosed partly or com-
pletely by a tumor can be spared by using intensity modula-
ted ion therapy. This is frequently necessary for tumors in 
the brain stem at the base of the skull. With rasterscanning 
the dose to this organs at risk can be drastically reduced. 
Using rasterscanning, the dose to the brain stem can be 
reduced far below normal tolerance limits for tissue. 
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Fig. 6: The rasterscan principle is the same tech-
nique as used with electrons in TV sets. The figure 
shows the reproduction of the famous photograph of 
Albert Einstein using a GSI’s rasterscan system as 
an ion TV. The image of Albert Einstein is produced 
using a 430 MeV/u carbon beam of 1.7 mm width 
(FWHM). The picture consists of 105x120 pixel filled 
by 1.5.1010 particles given in 80 spills (5 sec. each) 
of the accelerator. Original size of the picture: 15 cm 
x 18 cm.
If a critical organ, such as the brain stem, is 
completely or partially enclosed by a tumor 
it is important that the particle tracks are 
not passing through the critical organ. This 
is achieved by applying the beam from mul-
tiple channels in combination with advanced 
treatment planning algorithms. In the clinical 
practice two or three entrance channels are 
sufficient to reach an optimal sparing effect. 
However, the dose distributions for the diffe-
rent entrance channels can be extremely in-
homogeneous to reach a homogenous biologi-
cal effect in total. 
Using Intensity Modulated Particle Therapy 
(IMPT), an optimal agreement between ir-
radiated volume and planned target volume 
can be reached combined with a maximal 
sparing effect of critical structures, also in-
side the target volume. 
In many cases the dose gradient between tar-
get volume and critical organs is an important 
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Fig. 7: Isoenergy slices of a tumor. The target volume was 
dissected into about 60 slices which are covered with a grid of 
about 10 000 picture points (pixels) in total. At the right corner, 
one slice is shown enlarged. The circles correspond to the posi-
tion where the beam should be, the green points are the centers 
of the measured beams. Since the beam has a diameter of about 
6 mm, the beam at one pixel typically covers more than three 
pixels in each direction.
Fig. 8: Comparison of a 
treatment plan for carbon 
ions (left) and for protons 
(right). The carbon plan 
shows a very steep dose 
gradient. With such a steep 
dose gradient, the high dose 
area can be closer to the 
brain stem which is a cri-
tical organ shown in green 
at the left side. In addition, 
the proton plan was perfor-
med using a passive beam 
application system which 
allows a less satisfactory 
conformation to the target 
volume.
parameter for treatment planning. In Fig. 8 the planned 
dose distribution for carbon therapy (which was executed 
later on) and for proton treatment is shown. Both dose 
distributions were planned with the same treatment plan-
ning system based on the same patient data. Carbon ions 
have a three times steeper gradient for approximately all 
penetration depths. Therefore, tumors close to critical or-
gans can be treated with higher doses with carbon beams 
yielding a very low tumor recurrence rate.
The high precision of carbon beams and the low dose in 
the entrance channels allow for dose escalation in the 
tumor without increasing side effects. Therefore radio 
resistant tumors can be inactivated and the patient can 
be cured. 
Quality assurance of the beam application
Safe beam application in the patient requires precise 
knowledge of the irradiation geometry and an accurate 
positioning of the patient (Fig. 9).
In tumor diagnosis screening procedures 
are used, such as computer tomography 
CT or nuclear magnetic resonance (cal-
led: magnetic resonance imaging, MRI). 
In order to define size and position of a 
tumor, CT imaging is mostly sufficient. 
However, MRI is more suitable in defi-
ning the border of active tumor cells. 
Therefore MRI is used to produce the 
target volume for treatment. From CT 
data (Hounsfield units) without con-
trast-enhancing drugs, the density of the 
different tissues can be calculated and 
used to determine the carbon ion range. 
Dose in radiotherapy
The energy which is deposited per kilogram 
mass in a body is called dose. The dose is given 
in Gray:
1 Gy = 1 Joule / kg
The daily dose in an conventional radiation 
treatment is approx. 2 Gy, the total dose 
of a complete therapy between 60-70 Gy. 
Compared to other energies, these are small 
amounts of energy. For instance a dose of 2 Gy 
causes only a very small rise in temperature of 
a few thousands of a degree. This is far below 
a daily temperature cycle in our body. The 
action of ionizing radiation is not correlated 
with any temperature effect. Ionizing radiation 
destroys chemical bounds directly and afﬂicts 
very heavy damage to the biological system. 
For instance if the DNA is hit, the complete 
genetic information is destroyed locally.
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Fig. 9: Preparing a patient.
For the irradiation itself it is important that the beam hits 
exactly the target volume in the patient. 
Incorrect irradiation with a shift of only 1-2 mm would 
also destroy a part of the normal tissue, but much more 
important, it leaves part of the tumor cells without any 
dose. These cells survive and very rapidly cause a recur-
rent tumor.
In order to guarantee the precision of the irradiation pro-
cedure, a thermoplastic mask is manufactured for each 
patient at the Radiological Clinic Heidelberg (Fig. 10). 
The patient‘s mask is permanently attached to the patient 
couch, the patient is positioned, and the mask is attached, 
allowing for precise alignment. Under X-ray control, the 
necessary accuracy of 1 mm for the head and 2-3 mm 
along the entire spinal cord and in the pelvic region is 
ensured. The thorax and the abdominal region cannot be 
sufficiently immobilized through external means becau-
se of breathing and heart beat. There the target volume 
can move even though the body is immobilized from the 
outside. The possibility for treating moving tumors will 
be discussed later.
For most patients the immobilization 
mask is the most stressful part of 
heavy ion therapy. The mask covers the 
head very tightly and does not allow 
any movement. It is the purpose of 
the mask to ensure exact positioning 
the target volume. Because the mask 
ﬁts very tightly and immobilizes the 
patient, some patients feel helpless, 
especially during the ﬁrst irradiation 
which is often experienced as extreme 
psychological stress.
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Fig. 10: Immobilizing the head with a thermoplastic mask.
After a few irradiations, the patient gets used to 
the rigid mask. Nevertheless, the immobilization 
procedure is by far the most unpleasant part of all 
treatment sessions. The action of the ion beam in 
the body cannot be felt by the patient. However, a 
few patients see light flashes when the target vo-
lume is close to the optical apparatus. This "phos-
phen effect" is also known from space research, 
when cosmic rays impinge on the optical nerves or 
the retina of an astronaut. The phosphen effect is 
very weak and seen only in complete darkness. 
Also external immobilization should be sufficient. 
The position of the patient is controlled by at least 
two X-ray images of the target volume (taken per-
pendicular to each other). By detecting significant 
structures, such as bones or other anatomical land-
marks, the position of immobilization is controlled. 
In case of deviations greater than 1 millimeter, the 
patient will be repositioned and recontrolled. 
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Fig. 11: The collision of a carbon nucleus with an atom of 
the tissue can lead to an unstable carbon isotope that emits 
a positron (`+). The anihilation of these positrons produces 
two gamma-rays that can be detected from the outside with 
appropriate detectors. In this way the range of the original 
carbon beam in the patient can be visualized.
The PET analysis 
Besides these indirect methods of quality 
assurance the irradiation with ion beams offers 
for the ﬁst time the possibility of following 
and controlling the beam inside the patient.
During the passage of an ion beam through the 
patient‘s tissue, a small percentage of the pri-
mary beam is transferred to lighter fragments 
by nuclear reactions (Fig. 11). The fragments 
with smaller atomic numbers, which are the 
lighter elements between hydrogen and car-
bon, have a longer range than the primary car-
bon beam and cause a long dose tail beyond the 
target volume (see Fig. 3). However, a few of 
these nuclear reactions do not change the ato-
mic number, because only one or two neutrons 
are lost. In this way, carbon isotopes, such as 
carbon-10 and carbon-11, are produced. These 
isotopes are not stable and decay with a half-
time of 19 seconds and 20 minutes, respectively 
under the emission of a positron and a neutrino 
that later leaves the body of the patient. These 
unstable carbon isotopes 10C and 11C are stop-
ped nearly at the same position in the patient as 
the primary stable carbon beam and decay. The 
decay of the positrons can be monitored via the 
two emitted gamma-quanta from outside the 
body, using a positron emission tomography 
PET-camera (Fig. 12). With this method, the 
range of the primary beam inside the patient 
can be measured without any additional dose 
to the patient and presently with an accuracy 
of 2 millimeters.
The PET range control was developed by the 
FZ Rossendorf, Dresden and is very important 
for irradiations where a longer range could hit 
critical organs. PET control also helps to detect 
even small changes inside the irradiated area. 
Many patients undergo surgery before irradia-
tion. After the operation, swollen parts of the 
tissue decrease slowly in volume during the 
course of the radiation treatment. In addition, 
tissue-vacuoles -occurring after an operation- 
can be filled with water or mucus. These pro-
cesses change the geometry of the target volu-
me and reduce the precision of the irradiation. 
Using the PET analysis, all these changes are 
measured from day to day. In case of larger de-
viations, treatment planning has to be repeated 
based on a new CT.
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Fig.12: Patient positioned in front of the exit-
window before irradiation. The X-ray equipment 
is removed and positioned at the ceiling. The two 
heads of the PET-camera are above and below 
the patient's head. 
At the GSI therapy, a PET analysis is 
performed regularly for each patient 
treatment. The PET analysis visualizes the 
irradiation inside the patient. Based on 
the measured PET data, the accuracy of 
irradiation can be improved. In addition, - 
because of the PET analysis - the question 
of the fate of the carbon ions in the patient 
can be answered. 
The analysis of the measured PET data 
showed that the implanted carbon ions 
combine with oxygen ions, which are 
present everywhere to form CO2. CO2 is 
exhaled over the lungs in the usual brea-
thing cycle. The biological half time, i.e. the 
absorption of C-12 to CO2, of the carbon 
is about 100 sec and much shorter than 
the physical half time of about 20 min. The 
decrease to the measured PET signal re-
flects the biological recycling process of the 
oxygen.
However, the transport of the CO2 molecule de-
pends on the blood flow in the tissue. Tissue which 
has a normal blood flow is free from 11C ions in 
a very short time. In tissues with reduced blood 
flow, the implanted 11C ions stay longer. PET can 
measure this washout process of the carbon and 
determine the blood flow in the tissue as well as 
provide information on tissue reaction in response 
to irradiation. However, at present we have not 
quantified these data and do not know what infor-
mation we are able to obtain. Whether we can use 
these data to optimize the irradiation procedure 
has to be shown in future research. 
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Fig.13: In this comparison, 
the dose distributions and the 
expected distribution are com-
pared to measurements. The 
comparison shows that no cri-
tical regions, such as the brain 
stem, were hit. 
Moving tumors: inﬂuence of breathing
For high precision irradiation with the 
rasterscan technique, patients have to be 
immobilized with millimeter precision in order 
to irradiate the target volume as planned. 
Despite external immobilization, tumors in the 
thorax and pelvic region are moving because 
of the heart beat and breathing. 
For therapy of moving targets in the thorax re-
gion, two techniques are frequently proposed: 
synchronization of irradiation and breathing 
(gating) and repeated irradiation (multi-pain-
ting).
For gating, the breathing cycle is measured and the target 
is irradiated only when the lungs are empty in the short 
exhaled phase which is about 15 – 20 percent of the overall 
cycle. The rest of the time cannot be used for irradiation. 
This extends the irradiation time and makes the gating 
procedure less time efficient. The other technique, multi-
painting of the same volume increases the homogeneity 
compared to a single irradiation, however, not to the extent 
required for a few paintings. The periodicity of scanning, 
using a pulsed beam from the synchrotron can interfere 
with the breathing frequency. Even when irradiation is 
repeated a few times inhomogeneities of more than 5% 
are found that cannot be tolerated for therapy. A more 
frequent repetition increases the treatment time again. In 
addition, with this technique, the steep gradients at the 
border of the irradiation volume are lost. Most gradien-
ts are then determined by the amplitude and can reach 
values of a few centimeters. Accordingly, the treatment 
volume has to be extended into the normal tissue. For ex-
ample, for 1 cm3 large lung tumor, the treatment volume 
has to be enlarged to more than 30 cm3 for a peak-to-
peak breathing amplitude of approx. 3 cm.
A very efficient possibility to conserve precisi-
on and homogeneity for irradiation of moving 
targets consists of fast motion correction using 
the rasterscan system itself.
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Fig.14: Breathing causes tumor movement. In order 
to irradiate moving tumors, the beam has to be cor-
rected in the lateral direction and in depth. For lateral 
correction, the scanner can be used, for correction in 
depth a double wedge system has been developed, 
which is connected to a fast linear motor. When the 
two wedges move towards each other, the absorber 
gets thicker and the path length gets shorter. 
In the thorax region, organs are moving with a 
velocity of 3 cm per second and with maximum 
amplitude of 2–3 cm. In contrast, the magnetic 
scanning system has a lateral velocity in the pati-
ent of about 10 m/sec and is therefore 300 times 
faster than organ movement. Hence it is possible 
to correct the beam online in a lateral direction. 
The movement in depth would correspond to a fast 
correction in ions energy which is at present not 
possible from the accelerator. The corresponding 
energy correction has to be produced in less than 
one millisecond. Therefore a fast passive system 
was designed for energy correction. The energy is corrected by the energy loss in a double wedge 
system made of Plexiglas. These two wedges are mounted on linear motors and can be moved with 
high velocity against each other. Then the absorber thickness and, accordingly, the residual range can 
be varied.
The double wedge system combined with 
the rasterscan system has shown in test 
experiments that it is possible to reach a 
fast online correction for moving targets 
(Fig. 15). However, to use this system for 
patient treatment, it has to be integrated 
into the control system and the data of the 
actual movement inside the patient have 
to be transmitted to the control system. 
In addition, treatment planning has to be 
extended for the different phases of mo-
vement which are then requested by the 
control system. These completions to our 
existing therapy are at present a main to-
pic of the technical developments at the 
GSI. The developments are performed to-
gether with the radiology department of 
the Heidelberg University, the DKFZ, and 
in collaboration with Siemens Medical So-
lutions.
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Fig. 15: This figure shows the dose distribution inside 
a sphere of 5 cm in diameter, which was submerged 
in water. On the left side the sphere is not moving, 
in the middle, the sphere is simulating the breathing 
movement without any correction of the scanning 
system. At the right side, the online correction as 
described in the text has been applied and the origi-
nal precision of the static case can be reproduced. 
Experiments related to the biological 
effectiveness
In tumor therapy, heavy ions, such as carbon 
produce a better depth-dose proﬁle than protons. 
However, the essential advantage of carbon ions 
is the higher biological effectiveness at the end of 
their range in the tumor. In the entrance channel 
the RBE is only slightly elevated. In combination 
with the low dose in the entrance channel, less 
as well as more easily repairable damage is 
produced in normal tissue. An essential goal 
of the development of heavy ion therapy at GSI 
was to maximize the difference in the biological 
efﬁciency between entrance channel and tumor 
area.
The goal of the former heavy ion therapy at Ber-
keley was to maximize the absolute effects in the 
tumor area while taking into account greater side 
effects in normal tissue. Therefore Argon ions were 
chosen first and followed later on Neon ions. Both 
ions produce an extremely high tumor control rate 
but also many late effects in normal tissues. 
This clinical response of ion heavy beams can be 
explained with cell experiments: cells that are irra-
diated with carbon ions in different depths within 
a water tank as a tissue equivalent produce a cell 
survival that differs from the one known from ex-
periments with sparsely ionizing irradiation, such 
as photons (Fig. 16, mid panel). For carbon ions, 
the measured cell survival in the entrance chan-
nel is close to that of photons. But in the range of 
the Bragg maximum, carbon survival (red curve) 
Radiation quality and relative biological 
effectiveness RBE 
Radiation of different qualities can produce a different 
biological effect for the same physical dose. In 
radiation therapy sparsely ionizing radiation such as 
electrons, gamma, and X-rays (often called photons) 
are distinguished from densely ionizing radiation such 
as neutrons, alpha-particles, and heavy ions. The same 
dose of sparsely ionizing radiation produces the same 
biological effect. This is not true for heavy ions: different 
biological effects can occur for the same dose depending 
on the energy and atomic number of the ions. Ions 
produce along their trajectories a track of electrons and 
ionizations of high local dose up to a few thousand gray. 
Between these tracks, large areas of the nucleus are not 
hit by the beam (Fig. 20). The damage inside such a track 
is frequently not repairable and the biological action does 
not correlate with the macroscopic dose, because it also 
depends on the quality of radiation. In order to take care 
of these differences, the relative biological effectiveness, 
RBE, was introduced. 
The relative biological effectiveness is ﬁrst an empirical 
factor and can be calculated from measured data as the 
ratio between X-ray dose and ion dose which is necessary 
to produce the same effect. For heavy ion therapy at 
GSI, a theory of RBE was developed: the so called local
effect model LEM.
Biological basis of heavy ion therapy
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is much lower. It corresponds to an about 3 times 
higher dose than absorbed in the Bragg peak. This 
corresponds to a relative biological effectiveness of 
3 (RBE=3) (Fig. 3, low panel).
In Fig. 16 the RBE in the entrance channel is close 
to 1.5 and reaches at the end, before and in the 
Bragg maximum values of about 3.5. 
Similar behavior of the RBE is found for all ions. 
But for protons, the range of an elevated RBE is 
restricted to the last micrometers of the range, i.e. 
elevated RBE values are only found at the very dis-
tal parts of the Bragg maximum. Consequently, in 
clinical application the slightly elevated RBE va-
lues of protons are not important for therapy and 
are taken into account with a global factor of 10% 
– 15%, (RBE = 1.10 to 1.15). For very heavy ions 
-such as Argon- the increase of RBE starts very 
early in the entrance channel. This leads to the 
observed but unwanted side effects in normal tis-
sue. For carbon ions, however, the increase of RBE 
is restricted to the last 2 cm. This last part of the 
range can ideally be used in clinical application to 
very effectively destroy tumor cells in the target 
volume.
The reason for the difference in RBE can be 
explained by the microscopic structure of particle 
tracks and their interaction with DNA. 
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Abb.16: As a function of penetration-depth the 
dose, the survival, and the relative biological 
effectiveness RBE are compared for a carbon 
beam. In the top panel, the absorbed physical 
dose, i.e. the Bragg curve (in green) is com-
pared with the biological effective dose BED 
(in red). BED results from the absorbed dose 
multiplied by the RBE (lower panel). RBE is 
determined by comparing the expected survi-
val based on photon sensitivity (green, middle 
panel) with the measured survival (red). 
Microscopic understanding of RBE
During the slowing down process of heavy ions, 
energies between 10 eV and to a few 100 eV are 
transferred to the electrons of the tissue. These en-
ergies are small compared to the total energy of the 
carbon ion which is in the range of a few million 
electron volts (MeV). But they are big compared to 
the binding energy of the electrons of a few elec-
tron volts. Therefore, the electrons are liberated 
and leave the atoms with large kinetic energies. 
The energy of the liberated electrons is transmit-
ted to secondary ionizations and excitations. The 
ionizations destroy chemical compounds and, as a 
result, biologically important molecules. The most 
important target for the action of ionizing radiation 
in the cell is the DNA molecule which contains the 
complete genetic information. Because the integri-
ty of DNA is essential for survival of the cell and the 
complete organism, a very efficient repair system 
protects the integrity of the DNA.
In daily life DNA lesions are produced continuously 
in all tissues. Base-damage, single strand-breaks 
and most of the double strand-breaks are repaired 
fast and with high reliability. This is also true for 
most of the lesions which are produced by ionizing 
radiation. Only if a high local ionization density 
produces many DNA-lesions close to each other 
(clustered lesions), the repair may be frequently 
unsuccessful and the cell looses its ability to 
divide (clonogenic death) or the cells are forced 
to destroy themselves (apoptotic death). For 
sparsely ionizing radiations, the necessary high 
ionization density can only be reached with an 
increase in overall dose. 
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Fig.17: Schematic presentation of a DNA 
molecule exposed to a particle traversal. 
For carbon ions, high local ionization densities 
are reached in the center of each single track 
when the particle energy loss reaches values of a 
few 100 keV per micrometer or more. 
In Fig. 18, proton and carbon tracks are compared 
with a schematic representation of a DNA 
molecule. For protons, the energy loss is small 
and the individual ionization events are far from 
each other. This leads mostly to repairable DNA 
damage.
For carbon ions, the ionization density at the 
end of the track at low energies is high and local 
multiple damage sites of DNA (clustered damage) 
are very likely. 
The induction of these complex DNA damages over-
rules the repair system and the cells die after many 
trials to repair. This is also true for cells having an 
extreme large repair capacity which are otherwise 
very radio-resistant. However, because of the high 
local density of damage, even their repair capacity 
is not sufficient and the survival probability is dras-
tically reduced after irradiation with heavy ions. 
Therefore cell cultures that are resistant against 
sparsely ionizing radiation show the largest incre-
ase in radio-sensitivity, i.e. the highest RBE values 
if irradiated with carbon ions. This behavior of cell 
cultures can be directly transferred to tissue and 
tumors of a patient. 
In the clinical trials at GSI, preferentially slowly 
growing and therefore extremely radio-resistant 
tumors were irradiated with carbon ions. They 
showed the expected fast regression of tumors at 
low physical doses corresponding to a signiﬁcantly 
elevated relative biological effectiveness.
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Abb.18: The structures of proton and carbon tracks 
are compared to a schematically shown DNA mole-
cule. Sections of tracks are given at energies before, 
at, and behind the Bragg maximum. From the 
trajectory of the primary ion, the electrons that 
produce the biological damage are starting. For a 
carbon ion, a clustered damage can be produced 
that cannot be repaired by the cell and causes cell 
death.
In survival experiments, cell inactivation is measured 
as a function of the X-ray dose. In these experiments 
radio-resistant cells show normally shouldered survival 
curves: at low doses, the radio-sensitivity is small 
because most of the damage can be repaired. At 
higher doses, the sensitivity increases and the dose 
effect curves decrease much more steeply. This non-
linear behavior in form of a shoulder of the survival 
curve is mathematically expressed in a linear-quadratic 
function where survival is given as:
  
The coefﬁcient _ describes the linear fraction which 
is the slope at very small doses and gives the initially 
produced irreparable damage. The coefﬁcient `
describes the quadratic part, the inﬂuence of repair 
which is important for higher doses. The ratio _/` is
therefore a measure for the repair capacity. Cells or 
tissues of high repair potential exhibit a large shoulder 
with small _/` ratios between 1 and 3 Gy. Cells with 
small repair capacity have a large _/` ratio close to 
10 Gy.
For clinical application of carbon ions, 
radio-resistant tumors having small _/`
ratios are the best candidates. 
These are, for example, chordomas, chon-
drosarcomas, meningiomas, and of the mo-
re frequent tumors, prostate carcinomas, 
and non-small cell lung carcinomas, for in-
stance.
S = e -_uD
`uD
2	
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Fig.19 Cell survival is given as a function of the 
absorbed dose of X-rays or Carbon ions. For small 
carbon energies corresponding to the end of the 
range, the survival curves become steeper, indica-
ting a greater effectiveness of the particles. 
Calculation of the relative biological 
effectiveness RBE
RBE is a complex function of many parameters, 
such as dose, particle energy, and atomic number 
and, on the biological side, it is a function of 
repair capacity and size of the cell nucleus of the 
affected tissue. 
For correct treatment planning, these dependen-
cies have to be implemented in the calculation of 
local RBE values. This is extremely important 
when the beam is scanned and the composition of 
the radiation field and therefore the RBE changes 
from pixel to pixel. At GSI, the local effect model 
was developed for calculating the correct RBE va-
lues in the irradiation field. With this model, the 
particle action can be calculated on the basis of 
measured photon data. The reason for the eleva-
ted RBE is the different pattern of energy deposi-
tion of ions compared to sparsely ionizing radiati-
on. Comparing the dose distribution in small sub-
spaces of the cell nucleus, i.e. in the 
sub-micrometer region, the dose deposited by 
photons is more or less homogeneously distribut-
ed over the cell nucleus. For ions, the dose is con-
centrated in the tracks of each particle hit. For low 
energy ions, a large fraction of the cell nucleus is 
not covered with dose at all. Also inside the parti-
cles' track, the dose is not homogenously distri-
buted. It decays from very high doses in the center 
of the track according to a 2
1
r
 law to the border of 
the track (where r is the distance from the 
center). This law holds across several orders of 
magnitude corresponding to a central dose of ma-
ny kilo-Grays (kGy) up to a fraction of Grays (Gy) 
at the border of the track. But in the center of the 
track below a few nanometers the dose radial do-
se distribution has a flat top.
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Fig.20: Comparison of energy deposition for particles and X-rays 
in the frame of micrometers, i.e. in the frame of the cell nucleus: 
for x-rays, the dose is homogeneously distributed over the cell 
nucleus. For heavy particles, a large fraction of the cell nucleus is 
not hit and the dose is concentrated in a few very sharp spikes. 
This can also be seen in the distribution of the DNA damage 
(lower row). For X-rays, the damage (yellow) is homogenously 
distributed over the cell nucleus. For ions, the damage is concen-
trated at the location of particle traversals. Areas of such high 
local dose resist DNA repair.
The local effect model LEM
The basic principle of the local effect model LEM is 
to convolute the non-homogeneous dose distributi-
on in the particle track with the non-linear photon 
dose effect curve. With this procedure the effects 
of the particle can be calculated on the basis of the 
photon dose effect curve. 
In the calculations, the cell nucleus is covered with a particle 
density corresponding to the macroscopic dose (Fig. 21). The 
physical parameters, such as particle energy and atomic number, 
determine the radial dose distribution inside the particle tracks 
and the absolute dose. According to the radial dose distributions 
of the tracks, an inhomogeneous dose distribution across the 
complete cell nucleus is produced. Then the inhomogeneous 
dose distribution is dissected in submicrometer areas where the 
dose variation in each area is small compared to the absolute 
value of the dose. For each of these small areas, the number 
of lesions is calculated according to the photon dose effect 
curve and weighted according to the size of the area in relation 
to the total size of the cell nucleus. The total sum of lesions 
inside a cell nucleus is called N. Assuming Poisson statistics, the 
survival S can be calculated as S = exp (–N). A dose effect curve 
can be deduced by using many different particle coverings, 
i.e., different doses. In comparison to the X-ray dose-effect 
curve, the RBE is calculated. The main biological parameter of 
this calculation is the shape (the shoulder) of the photon dose 
effect curve i.e. the _/` ratio. The LEM calculations yield good 
agreement with experimental data and show that large RBE 
values are correlated to small _/` values and vice versa.
The fidelity of the LEM model was confirmed in 
many cell experiments and animal experiments. At 
the same time, LEM predictions were confirmed in 
non-biological systems, such as thermo-lumines-
cent detectors (TLDs) and photographic emulsions 
which have a non-linear dose response curve for 
sparsely ionizing radiation. In general, LEM has the 
power to calculate the particle dose effect curves 
of any system when the photon dose effect curve 
is known. 
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Abb.21: Principles 
of the Local Effect 
Model LEM (see 
text).
This generality of the LEM can be used for a biologically optimized treat-
ment planning. For each different composition of a radiation field, the 
RBE can be calculated point by point and used for treatment planning. 
This calculation yields large variations of RBE over the treatment volume 
according to the radio-resistance of the tumor or other tissues and the 
local dose. However, LEM does not contain any time parameters. In a 
protracted irradiation many lesions are repaired. There LEM overesti-
mates the biological effect in the entrance channel. But this means that 
the tissue there is in reality less affected by the radiation than predicted 
in treatment planning.
Comparison to mirco-dosimetry: 
Radiation oncologists who are used to work with neutrons propose to calculate the RBE for 
the physical doses using micro dosimetric response functions. This procedure is in principle 
not impossible but very difﬁcult. First, the response functions are not known, but they 
could be in principle measured for each tumor. However, this response function depends 
also on particle energy and atomic number. This means that for complex irradiation ﬁelds, 
not only one but many response functions should be measured. In addition, the response 
function depends on the dose. This means that the set of response functions has to be 
enlarged according to the number of possible doses. Without discussing now the possibility 
to measure all these data, it is evident that the procedure of micro-dosimetry does not 
reduce the data according to one simple dependence as it is possible in the case of LEM. 
In contrary, for each point of the target volume, a complete set of micro-dosimetric data 
is necessary for the different functional dependencies. Therefore the micro-dosimetric RBE 
distribution for treatment planning and documentation with heavy ion seems not to be 
practical because it requests an effort much lar-
ger than can be done. This is supported by the 
simple fact that up to now it was not possible 
to predict a single survival curve of an in vitro 
experiment according to mirco-dosimetric cal-
culations.
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Biological optimized treatment planning using RBE values 
The elevated relative biological effectiveness RBE is the most important 
advantage to use heavier ions, such as carbon for therapy. Only with 
heavier ions, is it possible to overcome the repair capacity of resistant 
tumor cells. However, RBE values have to be integrated correctly into 
treatment planning. As shown before, RBE is a complex function of 
many physical and biological parameters and it cannot be taken into 
account using one global factor for one tumor type.
According to the increased knowledge of recent years and the possibility 
to use larger and faster computers, the medical physicists are now able 
to calculate complex RBE distributions at any point of the irradiation 
field. This was not possible at the beginning of particle therapy at Ber-
keley. Therefore approximations had to be used there. With the cons-
truction of newer therapies, treatment planning of heavy ion therapy 
was improved step by step. For proton therapy, this improvement did not 
take place to this extent. 
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Fig.22: Three-dimensional treatment planning for car-
bon ions for a patient having a large tumor at the base 
of the skull. The dose can be focused exactly to the 
tumor. Normal tissues, such as eye balls, optical nerves, 
chiasm, and brain stem, are spared to a large extent. 
Protons
For protons, the RBE is increased only for the last frac-
tion of a millimeter of the range. This has been shown in 
cell experiments after clinical trails of protons had been 
started. For clinical use, RBE has been determined for ex-
tended volumes and an increase of 10 – 20 % was found. 
Therefore, in treatment planning for proton irradiations, 
the absorbed physical dose is currently multiplied with the 
global factor RBE = 1.1 to RBE = 1.2. This dose is then called 
the biological effective dose and is given in GyE (Gray equi-
valent). For tumor conform irradiations using a rasterscan 
system, this approximation might not be always appropria-
te. For this technique, RBE variations should be implemen-
ted at least at the proximal part of the planning. 
Heavy ions
Heavy ions, such as carbon exhibit much larger RBE va-
lues and a greater variation over a larger area of the 
range. This has to be taken into account in the entire 
planning procedure. The essential dependencies of RBE 
on physical parameters can be understood from an experi-
ment shown in Fig. 23. For an extended tumor volume the 
RBE increases to the distal part, i.e., to the maximal range 
because there Bragg peak ions contribute mostly to the 
dose. In the region closes to the surface, i.e., the proximal 
part of the target volume, the fraction of plateau ions is lar-
ge and consequently the RBE is small. In order to achieve a 
homogeneous biological effect across the complete tumor, 
the physical dose has to be decreased to the distal end. This 
is shown in Fig. 23 for all dose levels. However, by compa-
ring the RBE and the survival curves, it is evident that the 
RBE depends strongly on the dose: for high doses RBE is 
small, for a low dose RBE is large. 
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Fig.23: Comparison of measured RBE values in 
an extended volume as a function of penetration 
depth. A simulated tumor volume was exposed 
to different doses as shown in the upper row. 
The dose is modulated such that a homogenous 
cell death should be reached across the complete 
tumor region (middle curve). From the measured 
cell survival the relative biological effectiveness 
RBE was determined (lower curve). The results 
show that the RBE increases with depth and is 
largest for small carbon doses.
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of Tumor Therapy 
with Heavy Ions
Beams of heavy ions deposit a high and biologically very effective dose with great 
precision in the tumor. They represent the ideal tool for treating inoperable 
radio-resistant tumors combined with maximum sparing of the surrounding 
normal tissue.
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the research project: "Heavy Ion Tumor Therapy" at GSI with the ﬁnal objective 
to develop and improve the design for an advanced clinical heavy ion therapy 
unit for the tumor patients. As a result the following topics are supported:
Physical and biological research as the basis of heavy ion 
therapy.
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Improvement of the raster-scan system of GSI and its extended 
application to moving organs.
Biophysical experiments.
Design of advanced therapy units including an accelerator for 
clinical use.
Scientiﬁc conferences, publications, and information 
distribution to the scientiﬁc community and public regarding 
ion beam therapy and its application.
Promotion of the education of young scientists.
Awards young scientists with the Christoph Schmelzer Prize.
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View of the accelerating synchrotron. Dipole magnets (in red) 
at the left and right held the beam on its duty cycle while the 
quadrupoles (yellow) focus the beam. 
The Heidelberg Ion Therapy HIT
The gantry room during the assembling of the gantry structures.
Treatment room with the „patient“ robot at the 
floor and the „imaging robot“ at the ceiling. 
The patient robot will carry the patient couch 
and position the patient before the beam exit 
window. The imaging robot carries a X-ray 
tube and an image amplifier that are rotated 
around the patient to verify the position of 
the patient in relation to the treatment coor-
dinates.
Control panel of the HIT facility.
Pictures courtesy of HIT, Universitätsklinikum Heidelberg
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From the last chapter it is evident that RBE de-
pends heavily on the repair capacity of the affected 
tissue cells. In general, radio-resistant cells having 
a small _` ratio in the X-ray dose effect curves 
show extremely high RBE values. In treatment 
The Berkeley strategy (1975 – 1993) 
In the experimental therapy at Berkeley, the ion 
beam was adjusted to the target volume with pas-
sive elements, such as slits, apertures, range mo-
dulators, and compensators (Fig. 24). For the ran-
ge modulators, ridge filters were used which are 
saw-tooth like absorbers. The absorption in the 
thicker part of the teeth corresponds to a range in 
the proximal area and the absorption in the thin-
ner part of the teeth corresponds to a range in the 
distal part of the target volume. When the ridge fil-
ter is moved very fast over the irradiated area, the 
beam is modulated in depth at each position. The 
transition from thick to thin areas of the saw tooth 
determines the frequency with which the different 
planning for heavy ions, the dependency on dose, 
on particle energy, on the particle‘s atomic num-
ber, and on the repair capacity of the cells has to 
be taken into account very precisely. To do so, the 
different therapies have used different strategies. 
ranges are realized and consequently the shape of 
the decrease of the dose to greater depth. For a 
given shape of the mechanical ridge filter, the RBE 
weighting in depth is therefore fixed. It can neither 
be changed for different patients nor for fractiona-
tion schedules. For the ridge filters used at Berke-
ley, RBE depth-dose distributions and absolute va-
lues of the RBE have been adjusted to experimental 
data from in vitro experiments to human T1-cells. 
This was independent of the tumor to be irradia-
ted and independent of the fractionation scheme. 
The analysis of clinical data yielded in some cases 
deviation from the planned values in tumor reac-
tion. In these cases, the absolute RBE values and 
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Fig.24: The passive beam shaping 
systems have two tasks: lateral scat-
tering of the beam across the tumor 
volume and depth modulation. For 
lateral scattering, sophisticated sets 
of combined absorber foils are used 
to reach a homogeneous dose across 
the target volume. The outer contours 
are then defined by apertures. The 
depth modulation is more difficult, 
because the depth distribution has 
to contain also the information of the 
depth-RBE dependence. Therefore, 
the shape of the teeth of the ridge 
filters determines the depth-dose dis-
tribution. Finally, compensators in 
front of the patient can be used to 
shape the distal fall off. 
The strategy at Chiba (since 1993)
The heavy ion medical accelerator at Chiba, HI-
MAC was designed at "the peak" of the Berkeley 
neon therapy and was conceived as a technology 
transfer from California to Japan. Therefore, in 
the beginning the concept and many technical 
details were identical with the Berkeley unit. For 
historical reasons, the accelerator at Chiba is a 
double ring synchrotron where all ions from car-
bon to argon can be accelerated to a maximum 
the physical dose were changed correspondingly, 
however, the shape of the depth-dose distribution 
could not be fine-tuned. At the Berkeley therapy, 
many different sets of ridge filters were used for 
different tumor extensions and depths and for dif-
ferent RBE dependencies. But a correction of the 
depth-dose profiles to the radio-resistance of the 
energy of 800 MeV/u. This choice of particles was 
determined based on the Berkeley experience. 
Also for beam application a passive system is 
used that was changed in time to a semi-active 
system where the lateral scattering of the beam 
can be performed by a magnetic wobbler sys-
tem. Ridge filters are used for depth variation. 
The variation of RBE is integrated into treatment 
planning similar to Berkeley. 
tissue could not be achieved at Berkeley with the 
mechanical filter systems. For this purpose an 
even a larger number of tumor-specific absorber 
systems would have been required. In cell expe-
riments, these problems of the biological effecti-
ve dose have been measured and discussed. 
30

  
  	
 








  
  	
 








  
  	
 







Fig.25: Depth-dose profiles of the physical dose for different primary carbon energies. 
With human salivary gland cells, the shape of the RBE curve in depth was measured 
and transferred to an absorber design curve for different energies. For each of these 
energies a different ridge filter was produced (width of each SOBP indicated in the 
graph). These filters were used for all irradiations independent of tumor histology and 
fractionation scheme. 
Using Human Salivary Gland cells (HSG cells), RBE values were determined in 
cell experiments. For a spread out Bragg Peak (SOBP) the dose was corrected 
accordingly and veriﬁed in experiments. However, to transfer the RBE data to 
actual clinical application, the absolute RBE values of these in-vitro measurements 
were not used. Instead these data were compared to clinical neutron data. 
The cell experiment showed that in the middle of the extended Bragg maximum 
the RBE values of carbon ions for HSG cells showed the same RBE values as for 
neutrons. Therefore it was concluded in the same way that the RBE values from 
clinical experiments with neutrons could be transferred to the carbon therapy. 
As shown in Fig. 25, the RBE value for HSG cells was 1.6 in the middle of a 
3 cm SOBP of carbon ions. The same value was found for neutrons in a HSG 
experiment at an LET of 80 keV/um. For clinical application of the carbon beam, 
the data from neutrons showing RBE values of 3 are also used for the carbon ion 
in the middle of a 3 cm SOBP.
In a radiation field produced by a passive absorber, the RBE de-
pends only on the depth and there is no lateral RBE variation. 
Therefore the method used at Chiba is a very practical way for 
passive systems. The clinical experience shows agreement with 
treatment planning and very good clinical results could be achie-
ved at Chiba. 
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The Darmstadt strategy (since 1997)
In contrast to Berkeley and Chiba, a strict tumor-conform irra-
diation system was developed at GSI that completely avoided 
passive beam-forming elements. The purpose of the irradiation 
system is to individually adapt the beam intensity to the patient 
at each point of the irradiated volume. Using this intensity mo-
dulated particle therapy (IMPT), it is possible to adapt the dose 
distribution to any complex form of the target volume and also 
individually for any patient plan without producing always new 
patient-specific hardware, such as apertures and absorbers. 
Using the local effect model LEM, the local RBE at each pixel 
can be calculated for any radiation ﬁeld. This requires not 
only knowledge of the local dose for each volume element. 
Instead it also requires the composition of the radiation ﬁeld 
with respect to the physical 
parameters, i.e., the energy 
spectrum of the primary carbon 
ions and their fragments. 
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Fig.26: Shows the biologi-
cal dose, the physical dose, 
and the RBE distribution of 
a treatment plan.
The biological effective 
dose (top left) is a func-
tion of the physical dose 
(top right) which has to be 
multiplied with the rela-
tive biological effectiveness 
RBE (bottom). 
Treatment planning starts with a pure physical planning 
procedure just as it does in conventional therapy. The 
physician defines the outer contour of the target volume 
and the entrance channels for each CT slice which should 
not collide with critical structures such as the brain stem. 
For planning the target volume is transformed into the 
beam’s direction (beam's eye view). In contrast to conven-
tional therapy, planning starts with the optimization of the 
most distal slice of the target volume. 
This distal slice is planned for the prescribed dose by 
ions of an energy which produces a Bragg maximum 
at that range. The dose contribution of these ions in 
the more proximal slices is calculated and subtracted 
from the dose prescribed there. In the next step, 
the second distal slice is covered again with Bragg 
maximum ions of the corresponding lower particle 
range and this dose is subtracted from the proxi-
mal slices as well. The same procedure is repeated 
with the residual target volume until the complete 
target volume is ﬁlled with dose. After this proce-
dure, additional optimization for the total volume 
has to be performed because nuclear fragmentation 
causes scattering of a small dose fraction in forward 
direction and always affects the previous slice (Fig. 
27). During this physical optimization procedure, it is 
important that the information of the particle distri-
bution of the primary ions having different energies 
and the corresponding fragments is maintained, be-
cause RBE depends on these parameter.
Physical optimization of the treatment plan
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Fig.27: Schematic representation of treatment planning: in 
the first pure physical procedure the physical dose is opti-
mized. In a second step the relative biological effectiveness 
RBE for each pixel of the target volume is calculated and 
the biological effective dose is optimized. Finally, after 
some iteration, the control files for the scanner system are 
calculated.
Biological optimization 
In the second, more time-consuming step, the 
biological effective dose is optimized: for each small 
volume element (voxel) the actual RBE is calculated. 
For this procedure, the RBE values of the carbon ions 
of the different energies in the irradiation ﬁeld and 
their fragments are calculated separately. Therefore, 
it is important that in the previous step of physical 
optimization not only the dose fractions are optimized 
but also the origin of these fractions, i.e., the complete 
particle ﬁeld in each voxel is known.
After the local RBE values are calculated, the biological effective dose 
BED is calculated point by point: 
The biological effective dose distribution exceeds the planned 
physical dose. First it is remarkable that the highest RBE values are 
beyond the target volume (Fig. 26). There RBE values up to 10 are 
reached. The reason for these high RBE values is the RBE dependence 
on dose. RBE increases with decreasing dose and reaches a tissue-
speciﬁc limit. Beyond the distal part of the target volume, the dose 
is very small and therefore RBE values are high. However, from the 
distribution of the biological effective dose (Fig. 26 upper right) it 
is obvious that multiplication of the low physical dose with these 
high RBE values still yields small BED values and consequently small 
inactivation probabilities and steep dose gradients. In addition, two 
usually opposing ﬁelds are used in clinical routine. As a result, the 
distal dose of one side matches the entrance channel of the other and 
the high RBE values of one side are partially compensated for the RBE 
values of the opposite side. 
Important for treatment planning is the RBE distribution 
in the target volume and the resulting distribution of 
the biological effective dose, BED. After the first compu-
tational step, higher BED values are obtained than the 
prescribed dose. Therefore the particle covering in the 
target field is gradually reduced along with the point-by-
point recalculation of RBE until the new distribution of 
the biological effective dose corresponds to the nominal 
dose prescribed by the physician. Fig. 26 shows the dis-
tribution of absorbed dose, of RBE value, and of biologi-
cal effective dose for an optimized single field. 
BED = RBE · Dose
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Fig.28: Comparison of treatment plans for three 
patients with same tumor histology. The tumors 
were located at different depths and were irra-
diated with different doses (single field optimiza-
tion). Shown is the physical dose, the biological 
effective dose, and the RBE in the middle of the 
target volume. Depending on depth and dose value, 
the RBE varies even though it is the same tumor 
histology. This shows that the RBE is not a fixed 
parameter, but instead it has to be calculated on 
an individual basis. A similar effect occurs for the 
biological effective dose for the skin (arrow). The 
skin effective dose varies significantly from the 
tumor effective dose, although the physical dose 
remains the same.
Fig. 29 compares treatment plans of the same 
clinical case for different modalities indicating 
that carbon ions yield the best distribution when 
given with an active scanning system.
In these optimization procedures the tumor 
dose is maximized. It is also possible to deﬁne 
tolerance limits for the organs at risk. Then the 
physical dose deposited in the organs at risk 
can be weighted with the typically very different 
RBE for organs at risk to yield a minimal 
biological effective dose. In general, however, 
maximization of the effective dose in the target 
volume is mostly sufﬁcient. 
With these procedures an optimal BED 
distribution across the complete irradiated ﬁeld 
can be achieved: maximal dose to the tumor 
and minimal dose to the organs at risk which 
frequently can be spared completely. 
All patients at GSI have been treated according 
to this treatment planning procedure. Very 
good tumor control with minimal side effects in 
normal tissue justiﬁes the elaborate procedure.
From the RBE dependence on dose it is evident 
that it is not efﬁcient to distribute the dose 
over too many entrance channels. Because RBE 
increases with decreasing dose the sparing 
effect is not proportional to the dose reduction. 
In addition very small particle ﬂuences are 
difﬁcult to monitor in the ionisation and wire 
chambers.
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Fig.29: Comparison of the 
planned dose distributions of 
a carcinoma in the front part 
of the head. Upper left: IMRT 
planning with high energy 
photons. Lower left: passive 
proton application. Upper 
right: active application of 
protons. Lower right active 
application of carbon ions 
which yields the best dose dis-
tribution. (These figures are 
supplied by Dr. M. Krengli, 
CNAO, Italy.)
Documentation of the treatment
In heavy ion therapy, the medical prescription 
of the dose and documentation of the irradiation 
become difficult because of the inhomogeneous 
distribution of the physical absorbed dose.
In conventional therapy, the given dose corre-
lates in a unique way with the biological effect. 
Therefore the prescription of a certain dose and 
the documentation of the given dose is unique 
and sufficient. In proton therapy and in the for-
mer neutron therapy, the increase of biologi-
cal effectiveness was a constant factor across 
the complete irradiated volume. Therefore the 
absorbed physical dose was multiplied with a 
fixed RBE value which is approximately 1.15 for 
protons and approximately 3 for neutrons in or-
der to document the biological effective dose. 
For heavy particle therapy it is not possible to 
use this simple approximation: the RBE is not 
constant across the target volume, because it 
depends on particle distribution and dose. This 
means that different RBE values have to be used 
for the same type of tumor irradiated in diffe-
rent patients when the size and depth of the tu-
mor position are different or when a different 
fractionation scheme is used. 
This is a very important fact: in heavy particle 
therapy the clinician is not able to justify an ab-
solute value of RBE in a certain patient based 
on clinical experience. When he treats a new tu-
mor with the same histology in another patient 
who shows a different tumor size and position, 
the old RBE values cannot be used. However, 
the physician can very much determine the re-
sponse of the tumor: it is the radio-resistance 
in form of _/`ratios from which new RBE va-
lues for the next irradiation can be calculated 
according to the local effect model LEM. For 
the documentation of the irradiation in daily 
practice, this means that first the desired va-
lue of the biological effective dose, BED has to 
be documented. In addition, the physical dose 
distribution and the radio-sensitivity in form of 
the _/` ratio for the corresponding sparsely io-
nizing radiation have to be documented. From 
these data, the treatment planning and the ac-
tual treatment can always be reconstructed in 
a unique way. 
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Technical construction of the therapy at GSI 
In spring 1993 the installation of tumor therapy at GSI was started. First the shielded 
patient irradiation area (medical treatment room) was constructed and the beam 
lines including the scanning and monitor system were installed. In parallel the ne-
cessary changes of the accelerator and the control system were initiated. In order 
to guarantee the quality of patient irradiation, a novel quality assurance system had to 
be developed and tested. In addition, the complete accelerator control system had to 
be adapted to the new task: in physics experiments the beam is optimized by hand and 
then the accelerator is running for a long time (days or weeks) without any parameter 
change. The new therapy demands a completely different strategy: energy changes 
from second to second and from pulse to pulse with the same beam quality at the tar-
get are a must. In addition, it has 
to be assured that during patient 
treatment no parameter of the 
accelerator could be changed by 
other users or from the outside. 
In December 1997 the first pati-
ent could be irradiated at GSI. 
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Fig.30: Site plan of the GSI accelerator unit sho-
wing the ion-sources and the injector UNILAC 
followed by the heavy ion synchrotron SIS and 
the Experimental Storage Ring ESR. The thera-
py part is enlarged at the left side. It has an 
access over a maze. The isocenter of the beam 
is in the middle of the treatment room. 
In the new control system, the energy range 
relevant for therapy (80 MeV/u to 430 MeV/u, 
which corresponds to a range of 2 – 30 cm in 
tissue) is divided into 255 energy intervals that can 
be demanded from the therapy control system in 
any arbitrary sequence. Also the beam spot size 
and beam intensity can be changed. For the spot 
size 7 steps between 2.5 and 10 millimeters are 
possible. Beam intensity covers a range from 2·106
to 2·108 particles per pulse (15 steps). Only this 
type of ﬂexibility was it possible to perform patient 
treatments in a safe and quick way to ensure that 
the patient has to stay only a very short time in the 
patient immobilization system. 
In addition, a waiting area for the patients and 
rooms for the physicians for meetings as well as 
computer terminals for the PET system and for the 
treatment delivery control were provided.
The complete control system of the 
rasterscan and the accelerator merges 
into the technical control room (TKR,
Fig. 31). There the patient data, i.e., the 
control data of the rasterscan systems 
are loaded into the computers and the 
irradiation progress is controlled and 
monitored. For this purpose the dif-
ferent tumor slices are shown at the 
Therapy Online Monitor, TOM. A slice 
which is just under irradiation is shown 
in greater detail (see Fig. 7).
With the beam monitors in front of the 
patient, the beam positions are read out 
every 100 micro-seconds (i.e. 10 000 
times per second) and compared with 
the planned data. The beam intensity is 
measured 10 times more frequently in 
ionization chambers. In case of devia-
tions more than 5% of the dose in one 
pixel, irradiation is stopped and the error 
is shown. Also for other possible errors, 
irradiation can be stopped within half a 
millisecond at the accelerator and the 
error is shown at the control monitor. In 
case of an error that does not influence 
the quality of the complete irradiation, 
the dose application is continued at the 
same pixel where it was stopped.
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Fig.31: View of the control desk in the therapy control room TKR 
with the main control monitor in the center. 
From the TKR console it is possible to 
talk to the patient and to see him on the 
monitor (Fig. 31). He can be informed 
about the irradiation progress. One 
irradiation takes a few minutes in total. 
For the ﬁrst sessions, the time for set-up 
is longer. However, it becomes shorter 
when the patient is more experienced 
in this procedure. 
During irradiations at GSI, the patient is 
immobilized on the couch with a mask. 
The immobilization as such is control-
led via X-ray images. For this purpose, 
three X-ray systems are mounted to the 
ceiling of the irradiation area. They can 
be lowered down to the patient (Fig. 
12). With three X-ray systems and the 
corresponding image processors, two 
images of the patient's position are taken 
for control. In case of deviations of more 
than 1 mm, the patient is repositioned. 
When positioning is correct the patient 
couch is turned to the planned angle 
with respect to the beam and the X-ray 
system is moved to the parking position 
at the ceiling. Before irradiation starts, 
the PET camera is moved into position 
for therapy. The PET camera consists of 
two heads each containing 32 scintillati-
on detectors. In this camera the decay of 
the positron emitters, mainly 11C atoms, 
is measured from which the range of the 
beam in the patient can be extracted. 
The PET images are reconstructed after 
each treatment fraction.
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Fig.32: The upper part of the 
main control monitor shows 
a schematic representation 
of beam line (synchrotron, 
beam line, and rasterscan 
system), monitor system, 
and patient (resting on the 
couch and being covered by 
the PET system). The lower 
part contains the interface to 
handle treatment plans and 
a display that shows the irra-
diation progress.
For online control of the primary beam position, 
three ionization chambers and two position-sen-
sitive wire chambers are mounted at the beam 
exit window in front of the patient. The ioniza-
tion chambers are read out every 12 microse-
conds, the wire chamber is read approx. every 
100 microseconds. They produce the data for the 
control system and the therapy online monitor 
TOM (Fig. 7). Finally in each therapy room se-
veral laser systems are installed to position the 
patient. The online beam control is extremely 
important for the quality of the irradiation, but 
it is the speed of these monitors that determine 
the time of the patient exposure.
During the design of the complete therapy 
unit, care was taken to ensure a comfortable 
environment for the patient. The patient cannot 
see the large technical effort located ahead of 
the irradiation room. 
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Workﬂow of patient irradiation 
Diagnosis and planning
The medical responsibility for the therapy pilot project at GSI 
lies with the Radiological University Clinic in Heidelberg. All 
patients are examined there and the necessary diagnostic 
images are generated. These are normally CT and MRI images 
used to delineate the size and position of the tumor as well as 
measure functionality.
Prior to radiation therapy, many patients undergo surgery 
where a large part of the primary tumor is removed. For the 
residual tumor, the physician delineates the target volume in 
each CT slice. In addition, the physician defines organs at risk 
and the entrance channels of the beam. 
To calculate particle range, the different densities of the diffe-
rent tissue have to be taken into account in treatment planning. 
For this purpose, the gray values (Hounsfield numbers) of a 
calibrated CT image acquired without a contrast medium are 
used. These densities are transferred to energy loss values of 
carbon ions and used in the planning. However, for the dia-
gnostic imaging a separate CT image may be made using a 
contrast agent.
Based on this input data, the medical physicist at the DKFZ, 
Heidelberg calculates a treatment plan which is first optimized 
only according to the physical dose without taking into account 
the different biological effectiveness. The physical dose plan 
already allows for very good judgement of the treatment geo-
metry and the dose to the organs at risk.
After the physical optimization the plan is transferred to GSI 
where the RBE values are calculated and the biological effective 
dose, BED is optimized for each voxel of the target volume.
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The optimization procedure is iterated until the desired 
dose in the target volume is reached. For this optimized 
particle distribution, the control data for the rasterscan 
system are calculated. 
However, prior to patient treatment, the control data 
have to be veriﬁed. For this procedure the target ﬁeld 
is transferred to a water phantom and the critical parts, 
i.e., the gradients close to the brain stem are measured 
with thimble ionization chambers. Their positions in the 
target volume are ﬁrst transferred from the patient's 
inhomogeneous density distribution into the density 
distribution of a water phantom. In this transformed 
"water equivalent" target, the size of the target volume is 
changed, however the sharp contours in areas which could 
be reached in case of overrange of particles are maintained 
and can be examined. The successful examination of the 
control data of the raster system is a pre-requisite for using 
the data for the patient. 
While diagnosis and physical planning are ma-
de at Heidelberg, biological planning, treat-
ment plan verification, and the treatment itself 
have to be done at GSI in Darmstadt. However, 
in the new HIT facility in Heidelberg the work-
flow will be improved, because all these steps 
will be performed within one group at Heidel-
berg.
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Fig.33: CT-image of a patient before (left) and 6 weeks after 
(right) carbon therapy. In many cases the tumor disappears 
within a few weeks and so do the secondary symptoms of the 
disease (see Fig. 34).
Logistics of the treatment procedure and 
quality assurance 
GSI is mainly an institute for basic research. 
Only 20% of the total beam time is dedicated 
to therapy in 3 blocks a year at 4 weeks 
each. Each block treats 12 to 16 patients. 
The treatment of one patient is distributed in 
20 single fractions over 20 successive days, 
including weekends. 
Each block starts with a preparation phase 
of 4 to 5 days during which all accelerator 
settings and the rasterscan system are veriﬁed. 
This very elaborate quality assurance phase 
is necessary because the accelerators at GSI 
are used between treatment blocks for very 
different experiments and the accelerator 
system at GSI is rapidly developing. For a 
dedicated therapy accelerator with continuous 
patient throughput, this quality assurance 
phase can be reduced. 
The essential points of quality assurance are 
ﬁrst the accelerator functions. The carbon 
beam is checked to ensure that it is free of 
contaminations from different ions, that energy 
and intensity steps match the nominal values 
used for treatment planning, and that the 
beam spot sizes are independent of all other 
beam parameters. 
For the rasterscan system, the quality assurance 
affects mostly the position of the beam and 
the parallax, size, and stability of the beam 
spots in the target area. Of further interest is 
the accuracy of intensity and position monitors 
for a pristine beam as well as the quality of the 
calibration patterns produced by the scanner 
system.
These parameters are adjusted at the beginning 
of each treatment block. Part of this quality 
assurance is also performed each morning 
before patients are treated. With respect to 
the patient, correct patient positioning relative 
to the isocenter in the room coordinates has to 
be checked.
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For irradiation, the patient is immobilized in his individual mask 
which is adjusted using the laser system in relation to the coordi-
nates of the treatment room. This adjustment, especially the exact 
positioning of the patient in the mask, is controlled with two X-ray 
images taken perpendicular to each other. In case of deviations by 
more than 1 mm in the head area and 2 mm in the body, the patient 
is readjusted. This happens very seldom, except at the beginning of 
a series of irradiations while the patients are not used to the system. 
After one or two days, the patients experience less stress because 
the process has become routine and consequently the patients re-
main relaxed and introduce less misalligments.
After the adjustment, the patient couch is turned into the treatment 
angle and the PET camera is moved over the patient. Irradiation can 
now begin. The irradiation of one ﬁeld, this means the irradiation 
of the target volume from one side, takes about 3 – 5 minutes. 
Even this time will be reduced with the optimized system at HIT. 
After that, the couch is turned to the second treatment angle and 
patient irradiated again. Only in very rare cases irradiation with 3 
ﬁelds is necessary. 
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In the techniqual control room TKR, the different slices of the treatment 
volume are shown during irradiation. In addition, the individual pixels of the 
area which is just under treatment are shown in greater detail (Fig. 7). The 
course of irradiation is fully automated and proceeds without any manual 
interruptions or manual control from the control desk. Manual control would 
not be possible because of the high speed of the scan system of 10 meter per 
second. The human reaction time is at best in the order of 1 tenth of a second 
which would correspond to misirradiation of more than 1 meter, a value that 
lies far outside the tolerance limit.
The monitors of the control system measure the beam 
position every 100 microsecond, this means 10 000 times 
per second. It is therefore 1000 times faster than any 
manual intervention. An irradiation outside the given in-
tensity tolerance limits of maximal 5 % per pixel leads 
automatically within a few milliseconds to a beam stop 
in the extraction of the synchrotron. The status of the 
error is shown at the irradiation desk and the physician 
and the technical assistant have to decide whether this 
error in one of the approx. 10 000 pixels justiﬁes an in-
terruption of the entire irradiation or whether irradiation 
can be continued. This is usually the case and irradiation 
is continued at the pixel where it was interrupted. Ano-
ther reason for interrupting irradiation is an incorrectly 
functioning accelerator. In addition, the beam can always 
be interrupted manually. In case of any larger problem at 
the accelerator that requires a longer repair time, patient 
treatment has to be stopped for hours. However, the ma-
jority of patient treatments are not interrupted. 
The general experience made with the therapy 
provided by GSI therapy shows that up to 
now the heavy ion accelerator provides the 
same reliability (more than 95%) as clinical 
electron linacs. Almost all irradiations at GSI 
were performed without any interruptions. In 
a clinically-based system which is optimized 
for particle therapy only and does not have 
the complexity of the GSI accelerator, the 
interruption rate should be even lower. 
45
After irradiation, the patients are released from their immobilization 
and can leave the irradiation area. In one day, a total of up to 15 
patients with at least 2 ﬁelds can be treated. At GSI a large fraction 
of the total time, however, is not due the irradiation time itself 
but rather due to the time required for patient immobilization and 
positioning.
In a future clinical unit, 3-4 irradiation rooms will be operated in 
parallel. At least part of the patient immobilization will be performed 
outside the treatment room. There the accuracy of immobilization 
can be controlled using X-ray or ultrasound imaging. In total, 
patient throughput is determined to a greater extent by optimal 
patient preparation than by irradiation itself. Optimization of 
patient throughput is not only a question of economy. It is more 
important that the time spent by the patient in the unpleasant 
immobilization system is minimized as much as possible. 
Using improved methods of patient preparation and 
having 3 – 4 exposure rooms, a clinical unit will be 
possible to irradiate 1 500 – 2 000 patients per year 
with 20 fractions each. 
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Clinical results 
From December 1997 until the end of 2006, 
more than 340 patients have been treated with 
carbon ions at GSI. The results of these irradia-
tions can be analyzed in different ways:
The acute effects of irradiation, the tumor con-
trol rate, and finally the patient survival rate 
are the important criteria. 
In the following comparison, mostly the ﬁrst 
two points are used because the time span for 
closely evaluating the survival rate of most 
patients is too short. In addition, the tumor 
control rate is the most important factor 
for a comparison of different conforming 
methods.
Heavy ion therapy is a very localized therapy 
and the success of this local application can 
be taken as the main criteria: a therapy which 
has better local control is superior to a therapy 
which has less local control. In addition, the oc-
curance and intensity of side effects play a very 
important role, because the dose can only be 
escalated to a level with tolerable side effects. 
The side effects depend very strongly on 
maximal and integral dose in normal tissue. 
High local doses inactivate normal tissues 
and organs in the same way as tumors. Large 
integral doses which are below inactivation 
level favor the incidence of secondary 
tumors. As shown before, the dose and also 
the biological effective dose is much more 
precisely distributed in heavy ion therapy as 
compared to conventional therapy and also 
IMRT. 
Correspondingly less significant are also the 
observed side effects. It was also speculated 
that for heavy ion therapy the late effects such 
as the incidence of secondary tumors would be 
greater. It is too early to answer this question 
clinically. However we can make some projec-
tions.
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Fig.34: This tumor patient shows severe paralysis of the right side of the face caused 
by a large tumor in the skull. 6 weeks after heavy ion irradiation, these symptoms 
disappeared.
Secondary tumors have a latency period of so-
me years. But radiobiological cell experiments 
measuring cell transformation, i.e., the induc-
tion of cancer cells by carbon beams, are much 
faster and do not show a largely elevated RBE 
in the entrance channel. It was also speculated 
that using carbon ions, more neutrons would 
be produced, which could also lead to very se-
vere late effects. During carbon therapy, the 
dose produced by fast neutrons in normal tis-
sue was found to be much lower than 1% of the 
dose in the target volume. This is comparable 
to the neutron dose of a proton therapy with 
beam scanning. But it is much lower than the 
neutron dose produced in proton therapy with 
passive scattering methods. The low neutron 
production is due to the rasterscan system 
where no materials, such as collimators and 
compensators are in the beam in front of the 
patient, which would produce large amounts 
of neutrons in the direction of the patient. 
Therefore, for heavy ion therapy less 
late effects are expected in normal tissue 
compared to conventional therapy. 
The second criterion is the tumor control rate: 
this is defined as observing no tumor growth 
up to 5 years after treatment. There are not 
enough patients treated at GSI to make statis-
tically correct statements on 5 year tumor con-
trol rates for all tumor entities treated at GSI. 
In all cases, however, for the first 152 patients 
over the first 5 years very positive results were 
reached (Fig. 35). 
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Fig.35: Top – Local tumor control rate of patients 
suffering from an advanced carcinoma of the salivary 
gland. 29 patients are treated with a photon IMRT 
radiation combined with a carbon boost (upper curve). 
The lower curve shows the result of 35 patients trea-
ted with IMRT only. The boost irradiation with carbon 
ions increases the local control rate after 60 months 
from about 25 percent to 75 percent. 
Lower panel – Local tumor control rate for 44 chor-
doma patients (lower curve) and for 23 chordoma 
patients (upper curve).
In these patients slowly growing and consequently radio-
resistant tumors, such as chordoma and chondrosarcoma 
and malignant tumors of the salivary gland have been ir-
radiated. Because it is possible to immobilize the head in a 
very simple way using masks, the first tumors treated we-
re in the skull base, even though the geometry in the head 
is very complex. In the head, very different tissue densi-
ties, such as bones, soft tissue, and vacuoles are found 
very close together. Using the immobilization technique 
with a mask, sufficient accuracy of 1 mm or better could 
be reached. For patients treated at GSI, the first study of 
chordoma tumor patients revealed a tumor control rate of 
74% after 5 years, 23 chondrosarcoma patients showed a 
tumor control rate of 87% (Fig. 35). At NIRS 
in Japan, more patients have been treated 
than at GSI. Their results are listed together 
with the GSI data in the table on page 50. 
In general, these data show a better tumor 
control rate for all patients treated with car-
bons. For patients treated at GSI, the very 
precise irradiation technique using the ras-
terscan system yielded, in addition, a much 
smaller incidence of side effects as would be 
possible with conventional therapy. 
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International situation
Therapy with ion beams started at Berkeley with 
protons (1954) and with helium ions (1958). Be-
ginning in 1975 heavy ions were also tested at 
Berkeley: first argon beams were used because 
radiobiological experiments showed that radio-
resistant hypoxic tumors could be eliminated with 
argon ions. However, due to large side-effects in 
normal tissue, argon irradiation was stopped after 
a few patients. Also silicon irradiations were stop-
ped because due to considerable side-effects. Fi-
nally, the lighter neon ions did show tolerable side 
effects and approx. 420 patients have been treated 
at Berkeley with neon ions. In 1993, the Berkeley 
accelerator was closed and therapy ended. 
indication end point results, photons
results, ions 
-NIRS-
results, ions
-GSI-
Nasopharynx carcinoma 
(advanced state)
5y-S 40 - 50 % 63 %
Chordoma LCR 30 - 50 % 65 % 70 %
Chondrosarcoma LCR 33 % 88 % 89 %
Glioblastoma AST 12 month 16 month
Choroid melanoma 5y-S 95 % 96 %
preservation of 
eyesight
Paranasal sinuses 
tumors
LCR 21 % 63 %
Pancreatic carcinoma AST 6.5 month 7.8 month
Liver tumors 5y-S 23 % 100 %
Salivary gland tumors LCR 24 - 28 % 61 % 77.5 %
Soft-tissue carcinoma 5y-S 31 - 75 % 52 - 83 %
LCR: local control rate   PFSR: survival without tumor growth
5y-S: 5 year survival   AST: average survival time
In 1994, the National Institute of Radiological 
Sciences NIRS in Chiba, Japan started with car-
bon ion therapy. There, approx. 2 500 patients 
have been treated very successfully. In 1997, 
carbon therapy started at GSI in collaboration 
with the University of Heidelberg (Department 
of Radiation Oncology), the DKFZ, Heidelberg, 
and the FZR Dresden. The Darmstadt Therapy 
has the great advantage that an active applica-
tion system was installed and an extreme tar-
get-conform irradiation could be performed. 
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The highly satisfactory tumor control rates at 
Chiba and Darmstadt together with the low rate 
of side effects for conformed application were 
the reasons to start other carbon therapy pro-
jects. In Hyogo, Japan, a unit for carbon ions 
and protons started in 2002. The construction 
of a third Japanese unit in Gunma is under-
way. 
In 1992 an initiative for hadron therapy TERA 
was founded in Italy which first propagated a 
center for all hadrons, this means protons, neu-
trons, pions, and heavy ions. After a short time, 
this proposal was reduced to proton and carbon 
therapy only. In 2004, construction of a therapy 
unit was financed by the Italian government. 
The Centro Nazionale Adroterapia Oncologica 
CNAO was founded to build and operate this 
project. The TERA foundation accompanied 
this project with research. In Austria, Med-
AUSTRON, a project for the construction of a 
carbon-proton therapy was initiated. In the be-
ginning this project was combined with a Spal-
lation Neutron Source, using the same fast cyc-
ling synchrotron. However, after a short time it 
became evident that different accelerators, one 
for therapy and another for neutron production 
would be more efficient and as a consequence 
Med-AUSTRON was designing its own dedica-
ted therapy system. After the termination of the 
neutron spallation project, Med-AUSTRON con-
tinued separately. The construction of a therapy 
unit was decided by the government in January 
2005. In spring 2007 the State of Lower Austria 
provided 120 million € for construction.
In 1995 under the umbrella of CERN, the Eu-
ropean high energy nuclear research center in 
Geneva, a collaboration of different European 
institutes for an accelerator study, was started 
which was called Proton Ion Medical Machine 
Study, PIMMS. The goal was a European lay-
out that would produce modules for all national 
European projects. Parallel to this, the design 
of the Heidelberg therapy HICAT unit was pro-
duced at GSI.
The PIMMS collaboration and the increasing 
interest of the different projects resulted in a 
common discussion forum: the European Net-
work for Light Ion Therapy, ENLIGHT – under 
the umbrella of the European Society for Thera-
peutic Radiology and Oncology (ESTRO) at the 
European Union at Brussels. 
The workshops on Heavy Charged Particles in 
Biology and Medicine (HCPBM) started in 1982 
were used as a discussion platform for EN-
LIGHT and for the future development of heavy 
ion therapy. This workshop is now continued as 
conference Ion beams in Biology and Medicine, 
IBIBAM with a meeting at Heidelberg in Sep-
tember 2007.
In 2003, the construction of heavy ion therapy 
at the Heidelberg clinic was started. In 2005 in 
Pavia, close to Milano, the foundation stone for 
the Italian CNAO unit was laid and clinical ope-
ration is expected to start 2008. In May 2005 
funds were given by the French government for 
the design of the ETOILE project in Lyon. 
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Meanwhile in 2007, a second project at Marburg, 
Germany was started by a private hospital sup-
plier, the Rhön-Klinikum AG, RKA (Fig. 35). The 
investment in the Marburg ion beam unit was a 
part of the developing plan of RKA when buying 
the University clinics of Giessen/Marburg. In the 
next years, 5 units will be constructed in Europe 
the interest outside Europe is large as well. For 
an estimated need of about 1 unit per 10 million 
inhabitants these first 5 units are not sufficient. 
How many heavy ion therapies will be in operation 
in the end depends essentially on the clinical suc-
cess also in comparison to pure proton units which 
are about 30% cheaper in their investment costs. 
In the end, as is true for any big medical system, 
success will determine the number of units. In the 
European market Siemens Medical Solutions has 
taken over GSI know-how and GSI patents. The 
Belgian company Ion Beam Application IBA, as 
well as the German company ACCEL, are produ-
cing and offering heavy ion therapy. In Japan, Mit-
subishi is selling heavy ion therapy systems.
The large interest of these companies shows that 
an important market for heavy ion therapy is ex-
pected to benefit many patients and increase their 
chances for a cure.
Fig.36: Layout of the Marburg Heavy Ion Therapy of the Rhön Klinikum AG. The ion source and the synchrotron on 
the right produce the beam for three irradiation areas having a fixed horizontal beam similar to GSI. In the fourth 
treatment room far left, the beam is injected at 45° degrees which allows for additional entrance channels. These 
treatment room are marked in green. The patient area (marked yellow) contains examination-immobilisation rooms 
and two CT rooms (left and right). Room for the physians (magenta) and medical physisicts (blue) are in the upper 
front folloved by radiobiological laboratories and rooms for radiobiologists (pink). The Marburg facility will be cons-
tructed and operated by Siemens Medical Solutions.
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